Monthly Archives: October 2015

NCCP 2015 – National Conference on “Clinical Research and Personalized Therapy”, JIPMER, Puducherry | DECEMBER 30 & 31,2015

NCCP 2015 – National Conference on “Clinical Research and Personalized Therapy”, JIPMER, Puducherry | DECEMBER 30 & 31,2015

Two pre conference workshops on “Good Clinical Practice in clinical trials” and “Research Methodology” will be held on 29th December 2015

Topics for NCCP 2015 – National Conference on “Clinical Research and Personalized Therapy”, JIPMER, Puducherry.
Theme: “Clinical trials in genomic era”
– Pharmacogenomics in India
– Translational genomics
– Genomics in clinical trial designs
– Personalized therapy in diabetes mellitus
– Personalized therapy for mental health
– Genomics in drug safety
– Genomics in cancer therapy & research
– Advancing cancer care through clinical trials
– Personalized cancer chemotherapy
– Scope of personalized medicine in radiotherapy
– Clinical trials with biologics
– Cardiovascular Research: Innovative approaches
– Study designs in cardiovascular clinical trials
– Personalized therapy in cardiovascular diseases
– Genomic concepts in cardiovascular clinical trials- challenges ahead
– Recent advances & challenges in clinical trial
– Strategies for personalizing conditioning regimen prior to stem cell transplantation
– Biorepository: Mining clinical data
– Future perspectives of clinical trials in personalized medicine

For more details: visit: http://nccp2015.jipmer.edu.in/

Courtesy: Dr. Alph Stanley, Senior Resident | JIPMER, Puducherry

0

IPSCON-2015 | December 17-20, 2015

 

 

 

 

 

 

IPSCON-2015  | International Conference on
“Cutting-Edge Pharmacology: Contemporary Issues and Future Challenges” & 48th Annual Conference of Indian Pharmacological Society. This time it will be organised by Department of Pharmaceutical Sciences,
Saurashtra University, Rajkot, Gujarat, INDIA.

Preconference Workshop: 17 December 2015

Conference: 18-20 December 2015

The official website – click

The details of registration can be found here.

 

 

 

 

0

Basic Workshop on Software for scientific Research

image

image

Basic Workshop on Software for Scientific Research will be conducted by IGMC&RI,Puducherry on November 6,2015. The registration fee for this one day event is ₹750.

0

A love spat between ex-employees of GVK biosciences opened up a can of worms which kept the biggie’s reputation at stake

In a special report, The Hindu reports on how a love affair between two staffers of GVK Biosciences – one of the largest Contract Research Organisations based in Hyderabad – spiralled into a blow for the company’s business. “A torrid love affair between two employees resulted in the international scrutiny of GVK Biosciences and a ban on marketing of around 700 generic drugs tested by the facility,” says this report.

Read about the fall in stocks and closure of trading here.

What did Dr.G.N.Singh mean when he stated “Having said that, one must understand that there is a bigger game being played out here” to an interview by Hindu?

What’s your comment on this?

0

Current status of Healthcare in India: Dr.Vishal Bali

 

 

Dr.Vishal Bali says: “Healthcare needs to be made into a national agenda if India aims to provide affordable means of treatment based on new age technology to its citizens”

Read What he said to ETHealthWorld.com here.

0

A curious Case of Turing Pharmaceuticals & Daraprim

Martin Shkreli (CEO of Turing Pharma): “I’m not affected by the anger. I don’t think much about the wider world. I work with my patients.”

Photograph: The Gaurdian

 

Read what “The Guardian” had published: Click

Beyond the Curious case of Turing pharmaceuticals and Daraprim (Pyremethamine) lies a fact how economical to get this drug in India. Check the prices here.

P.S: Also an example of non-cancer use of Leucovorin or Citrovorum Factor or Folinic Acid as a rescue agent. The high does of Sulfadoxine and Pyrimethamine in cases of immunocompromised patients infected with T.gondii demands a “Rescue”!

Read More about Daraprim here.

Dr.Arun Kumar: CEO of ADR-Plexus-A PG Entrance coaching institute, posted on his on this facebook wall:

Pyrimethamine is given for following diseases
1. In combination with a long-acting sulfonamide such as sulfadiazine, it is used for Plasmodium falciparum malaria
2. Actinomycosis
3. Isosporiasis
4. Pneumocystis jirovecii
5. Toxoplasmosis
Trade Name for Pyrimethamine is Daraprim . There are many shared post in facebook portraying Martin Shkreli as a Villain and worst businessman who escalated the price of the drug which is being used for treating toxoplasmosis in AIDS Patients . ….
But No One knew the hidden truth behind the sudden rise in price of this drug ….
Pyrimethamine is actually a novel drug and In 2011, a new research found out that pyrimethamine can increase ß-hexosaminidase activity, which helps in slowing down the progression of late-onset Tay–Sachs disease.
A series of clinical trials was initiated by many scientist to find out the beneficial role of Pyrimethamine in amyotrophic lateral sclerosis ….Oh yes You Guys Got it….It is the same disease for which you shared ICE BUCKET CHALLENGE ….. Very soon you can expect the approval of FDA for the use of pyrimethamine in ALS…
Guess what will happen in coming years…….Pyrimethamine rates will escalate to 5,00,000 rupees from existing Rs 49,500.
A research which is made inaccessible for Mankind is worth for nothing.

1+

Users who have LIKED this post:

  • avatar
↓